Plain-English translation of NCT05322213 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 Diabetes research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Researchers want to understand whether —a compound found in cannabis—might affect how your body manages blood sugar and how well your blood vessels work. This is a basic science study, meaning it's designed to gather information about how the medication works in people with type 2 diabetes, rather than to prove it treats the condition. You'll try both and a placebo (a product with no active ingredient) over two separate 2-week periods.
Type 2 diabetes affects how your body handles blood sugar, and it can also damage blood vessels over time. Scientists are exploring whether this medication might help with either of these problems, but first they need to carefully study how it works in people with this condition.
You likely qualify if…
You likely don't qualify if…
You'll visit the clinic 10 times over about 4 months. First, you'll complete screening visits with blood tests and heart tests. Then you'll inhale your assigned treatment (either or placebo) daily for 2 weeks, with check-ins to make sure you're using it correctly. At the end of the first 2 weeks, you'll have tests to measure how your blood vessels work and how your body processes sugar. After a 4-week break, you'll repeat the same process with the opposite treatment. Throughout the study, you'll keep taking your regular diabetes medications.
AI-generated summary from trial data · Jun 21, 2026 · Not medical advice
United States